Participants were aged between 40 and 79 at the start of the study, which began in the ’90s ― but the data which scientists ...

Feb. 11, 2025 — A complementary drug to combat Alzheimer's disease could target a specific part of the nerve cell protein tau. This is the finding of new research which also offers a better way ...

Feb. 12, 2025 — A study reveals that traumatic brain injury alters the small vessels in the brain, resulting in an accumulation of amyloid beta -- a hallmark of Alzheimer's disease. The findings ...

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Registered office at Alzheimer's Society, 43-44 Crutched Friars, London, EC3N 2AE Alzheimer's Society is a registered Charity No. 296645. Registered as a company limited by guarantee and registered in ...

Eric Katz writes about federal agency operations and management. His deep coverage of Veterans Affairs, Homeland Security, the Environmental Protection Agency and U.S. Postal Service has earned ...

Short-term memory loss can be a sign of early-stage Alzheimer's disease. It can manifest as difficulty creating new memories or problems retrieving them. For example, someone with early Alzheimer's ...

Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars ...

With expertise in research, fundraising, policy and more, our staff are dedicated to making breakthroughs possible. Hilary Evans-Newton is the Chief Executive of Alzheimer’s Research UK. Hilary joined ...

Eric Deggans is NPR's first full-time TV critic, also serving as media analyst and guest host for the network. Deggans came to NPR in 2013 from the Tampa Bay Times, where he served as TV/Media ...